Cysteinyl leukotriene receptors in the human lung: What's new?

Trends in Pharmacological Sciences

Volumn 17, Issue 10, 1996, Pages 342-345

  Gorenne, Isabelle ^a   Norel, Xavier ^b   Brink, Charles ^b  

^a GRADUATE HOSPITAL   (United States)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 METHOXY 4 [(PHENYLSULFONYLAMINO)CARBONYL]BENZYL] 1H INDAZOLE 6 CARBAMIC ACID CYCLOPENTYL ESTER; 4 (4 CARBOXYPHENYLTHIO) 7 [4 (4 PHENOXYBUTOXY)PHENYL] 5 HEPTENOIC ACID; 6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; CYSTEINYL LEUKOTRIENE 1 RECEPTOR; CYSTEINYL LEUKOTRIENE 2 RECEPTOR; CYSTEINYL LEUKOTRIENE RECEPTOR; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; PEPTIDOLEUKOTRIENE; POBILUKAST; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VERLUKAST;

ARTICLE; ASTHMA; BRONCHUS MUSCLE; DRUG ANTAGONISM; HUMAN; LUNG; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; SMOOTH MUSCLE CONTRACTILITY; TISSUE DISTRIBUTION;

EID: 0030273744     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0165-6147(96)10044-4     Document Type: Article

References (27)

1. 1 Samuelsson, B. (1983) Science 220, 568-575
2. 2 Dahlén, S-E. et al. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 1712-1718
3. 3 Lam, S. et al (1988) J. Allergy Clin. Immunol. 81, 711-717
4. 4 Taylor, L. K. et al. (1992) J. Allergy Clin. Immunol. 89, 575-583
5. 5 Dahlén S-E., Hedqvist, P., Hammarström, S. and Samuelsson, B. (1980) Nature 288, 484-486
6. 6 Schellenberg, R. R. and Foster, A. (1984) Prostaglandins 27, 475-482
7. 7 Hedqvist, P. et al. (1980) Acta Physiol. Scand. 110, 331-333
8. 8 Marom, Z. et al. (1982) Am. Rev. Respir. Dis. 128, 449-451
9. 9 Coleman, R. et al. (1994) Adv. Prostaglandin, Thromboxane and Leukotriene Res. 23, 283-285
10. 10 IUPHAR TIPS Suppl. (1995) Receptor and ion channel nomenclature supplement pp. 42-43
11. 11 Drazen, J. M. et al. (1980) Prof. Natl. Acad. Sci. U. S. A. 77, 4354-4358
12. 12 Fleisch, J. H. Haisch, K. D. and Spaethe, S. M. (1982) J. Pharmacol. Exp. Ther. 221, 146-151
13. 13 Snyder, D. W. and Krell, R. D. (1984) J. Pharmacol. Exp. Ther 231, 616-622
14. 14 Buckner, C. K. et al. (1986) ,. Pharmacol. Exp. Ther. 237, 558-562
15. 15 Jones, T. R. et al. (1989) Can. J. Physiol. Pharmacol. 67, 17-28
16. 16 Krell, R. D. (1989) Pulm. Pharmacol. 2, 27-31
17. 17 Lewis, M. A. et al. (1984) Prostoglandins 27, 961-974
18. 18 Mong, S. et al. (1985) Eur. J. Pharmacol. 106, 241-253
19. 19 Frey, E. A., Nicholson, D. W. and Metters, K. M. (1993) Eur. J. Pharmacol. 244, 239-250
20. 20 Rovati, G. E. et al. (1985) Biochem. Pharmacol. 34, 2831-2837
21. 21 Labat. C. et al. (1992) J. Pharmacol. Exp. Ther. 263, 800-805
22. 22 Gorenne, I. et al. (1995) Eur. J. Pharmacol. 275, 207-212
23. 23 Burke, J. A., Levi, R., Guo, Z. G. and Corey, E. J. (1982) J. Pharmacol. Exp. Ther. 221, 235-241
24. 24 Ortiz, J. L. et al. (1995) Br. J. Pharmacol. 115, 1382-1386
25. 25 Moncada, S., Gryglewski, R., Bunting, S. and Vane, J. (1976) Nature 263, 663-665
26. 26 Furchgott, R. F. and Zawadzki, J. V. (1980) Nature 288, 373-376
27. 27 Tudhope, S. R. et al. (1994) Eur. J. Pharmacol. 264, 317-323